ConductScience.org, home

Paper5285387

Clinical implications of enzyme induction.

Breckenridge A and 1 other. Ann N Y Acad Sci, 1971. Cited by 82 papers, by iCite.

Cite this record

ConductScience Library. Clinical implications of enzyme induction. Papers, record 5285387. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/5285387

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Clinical implications of enzyme induction.
PubMed
Journal
Ann N Y Acad Sci
PubMed
Year
1971
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
82
iCite
Relative citation ratio, by iCite
3.69
iCite
Revised in PubMed
2019-06-16
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Breckenridge AA
2Orme MM

Source PubMed

Download CSV of authors

Topics30

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Enzyme InductionMajor topic
Hypnotics and SedativesMajor topic
WarfarinMajor topic
Alcohols
Amobarbital
Animals
Antipyrine
Benzazepines
Blood Coagulation
Chloral Hydrate
Chlordiazepoxide
Ethanol
Fluorometry
Half-Life
Humans
Hydrocortisone
Ketones
Kinetics
Male
Metabolism
Microsomes, Liver
Morphinans
Nitro Compounds
Paralysis
Phenobarbital
Rats
Rheumatic Heart Disease
Secobarbital
Sleep
Time Factors

Source PubMed

Download CSV of topics

Cited by25

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 82 citations.

PMIDTitleJournalYearIn PapersSource
12755806Progress in clinical pharmacology over the last 20 years.Br J Clin Pharmacol2003https://conductscience.org/library/papers/12755806PubMed
10885586Induction of drug metabolising enzymes: pharmacokinetic and toxicological consequences in humans.Clin Pharmacokinet2000https://conductscience.org/library/papers/10885586PubMed
9839089Inhibition and induction of cytochrome P450 and the clinical implications.Clin Pharmacokinet1998https://conductscience.org/library/papers/9839089PubMed
9084959Protease inhibitors in patients with HIV disease. Clinically important pharmacokinetic considerations.Clin Pharmacokinet1997https://conductscience.org/library/papers/9084959PubMed
7397454Phenobarbitone interaction with oral contraceptive steroids in the rabbit and rat.Br J Pharmacol1980https://conductscience.org/library/papers/7397454PubMed
6873139Biotransformation of amitriptyline in alcoholic depressive patients.Eur J Clin Pharmacol1983https://conductscience.org/library/papers/6873139PubMed
6705425Pharmacokinetic consequences of drug displacement from blood and tissue proteins.Clin Pharmacokinet1984https://conductscience.org/library/papers/6705425PubMed
6347619Drug interactions with warfarin.Drugs1983https://conductscience.org/library/papers/6347619PubMed
6114852Triazolam: a review of its pharmacological properties and therapeutic efficacy in patients with insomnia.Drugs1981https://conductscience.org/library/papers/6114852PubMed
6113907Clinical implications of enzyme induction and enzyme inhibition.Clin Pharmacokinet1981https://conductscience.org/library/papers/6113907PubMed
5071697Interactions of benzodiazepines with warfarin.Br Med J1972https://conductscience.org/library/papers/5071697PubMed
4817187Interaction between doxycycline and barbiturates.Br Med J1974https://conductscience.org/library/papers/4817187PubMed
4717418Benzodiazepines and tricyclic antidepressant plasma levels.Br Med J1973https://conductscience.org/library/papers/4717418PubMed
4637511Changes in human drug metabolism after long-term exposure to hypnotics.Br Med J1972https://conductscience.org/library/papers/4637511PubMed
4600204Interaction between doxycycline and some antiepileptic drugs.Br Med J1974https://conductscience.org/library/papers/4600204PubMed
4593987[Drugs interacting with coumarine oral anticoagulants (author's transl)].Klin Wochenschr1973https://conductscience.org/library/papers/4593987PubMed
4417891Urinary D-glucaric acid excretion and acetanilide pharmacokinetics before and during diphenylhydantoin administration.Eur J Clin Pharmacol1974https://conductscience.org/library/papers/4417891PubMed
4405530Changes in plasma -glutamyl transpeptidase activity associated with alterations in drug metabolism in man.Br Med J1973https://conductscience.org/library/papers/4405530PubMed
3841364Population pharmacokinetics of racemic warfarin in adult patients.J Pharmacokinet Biopharm1985https://conductscience.org/library/papers/3841364PubMed
2874223Metabolic basis of adverse drug reactions.J R Coll Physicians Lond1986https://conductscience.org/library/papers/2874223PubMed

See all 25 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/5285387

GET https://conductscience.org/api/papers/v1/5285387/cited_by?page=2